The British Society for Haematology (BSH) Lymphoma Special Interest Group (SIG) primarily has an educational role. The educational events cover both the clinical aspects of lymphoma diagnosis and management as well as basic scientific and translational science. Lymphoma research will remain the remit of the lymphoma NCRI Lymphoma Clinical Studies Group.
The group organises one educational event every year in autumn, in different geographical locations, and two business meetings per year. A second educational meeting might be held during the ASM, subject to the approval of the BSH Programme Committee.
The SIG committee has 11 elected representatives, members of the BSH, with one reserved position for each of the devolved nations. There are also co-opted members representing specialist nursing, imaging, histopathology and members in training. There are therefore be a total of 15 committee members. It is hoped that there will be even geographical representation but the elected members are all elected on the basis of votes cast without reference to their geographic location except for the reserved positions mentioned above. The Chair is chosen from within the Committee, once elected, during the first business meeting.
Members serve a three year term or less if agreed to allow a staggered rotation.
The BSH Lymphoma SIG offers advice and professional opinion to and through the External Affairs Committee when requested to do so.
Chair - Dr Kate Cwynarski
For more information email: email@example.com or call 020 7713 0990
Join the Lymphoma Special Interest Group The SIG welcomes both members and non-members of the BSH who have a special interest in lymphoma and is free to join.
Tuesday 28th April Lymphoma SIG Session at ASM 2020
This session is themed around the BSH at 60 years; what we have achieved and where the field of Lymphoma is going over the coming years
1. Professor Judith Trotman Senior Staff Specialist and Director of the Clinical Research Unit in the Haematology Department, Concord Hospital, Australia: Functional imaging: ‘PET-pearls, PET-falls: the role of PET in Follicular lymphoma’
2. Dr Catherine Burton, Consultant Haematologist, Leeds Teaching Hospitals NHS Trust: Molecular biomarkers in lymphoma
3.Dr Christopher Fox Chair, NCRI lymphoma high-grade sub-group: Clinical prognostication in lymphoma
‘Meet the Professor’
BSH Vice President Professor Simon Rule – in conversation with two trainees (Dr Emma Searle and Dr Elizabeth Phillips on the future of Haematology, shape of trials in the future, career opportunities, and imbalances.